Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Development ; 134(10): 1861-71, 2007 May.
Article in English | MEDLINE | ID: mdl-17428827

ABSTRACT

The correct organization of cells within an epithelium is essential for proper tissue and organ morphogenesis. The role of Decapentaplegic/Bone morphogenetic protein (Dpp/BMP) signaling in cellular morphogenesis during epithelial development is poorly understood. In this paper, we used the developing Drosophila pupal retina--looking specifically at the reorganization of glial-like support cells that lie between the retinal ommatidia--to better understand the role of Dpp signaling during epithelial patterning. Our results indicate that Dpp pathway activity is tightly regulated across time in the pupal retina and that epithelial cells in this tissue require Dpp signaling to achieve their correct shape and position within the ommatidial hexagon. These results point to the Dpp pathway as a third component and functional link between two adhesion systems, Hibris-Roughest and DE-cadherin. A balanced interplay between these three systems is essential for epithelial patterning during morphogenesis of the pupal retina. Importantly, we identify a similar functional connection between Dpp activity and DE-cadherin and Rho1 during cell fate determination in the wing, suggesting a broader link between Dpp function and junctional integrity during epithelial development.


Subject(s)
Drosophila Proteins/physiology , Signal Transduction , Animals , Body Patterning , Bone Morphogenetic Proteins/metabolism , Cadherins/metabolism , Cell Adhesion , Cell Lineage , Drosophila , Drosophila Proteins/metabolism , Epithelium/embryology , Pupa/physiology , Retina/embryology , Temperature , Wings, Animal/embryology , rho GTP-Binding Proteins/metabolism
2.
Psychopharmacology (Berl) ; 190(3): 269-319, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16896961

ABSTRACT

RATIONALE: This review provides insight for the judicious selection of nicotine dose ranges and routes of administration for in vivo studies. The literature is replete with reports in which a dosaging regimen chosen for a specific nicotine-mediated response was suboptimal for the species used. In many cases, such discrepancies could be attributed to the complex variables comprising species-specific in vivo responses to acute or chronic nicotine exposure. OBJECTIVES: This review capitalizes on the authors' collective decades of in vivo nicotine experimentation to clarify the issues and to identify the variables to be considered in choosing a dosaging regimen. Nicotine dose ranges tolerated by humans and their animal models provide guidelines for experiments intended to extrapolate to human tobacco exposure through cigarette smoking or nicotine replacement therapies. Just as important are the nicotine dosaging regimens used to provide a mechanistic framework for acquisition of drug-taking behavior, dependence, tolerance, or withdrawal in animal models. RESULTS: Seven species are addressed: humans, nonhuman primates, rats, mice, Drosophila, Caenorhabditis elegans, and zebrafish. After an overview on nicotine metabolism, each section focuses on an individual species, addressing issues related to genetic background, age, acute vs chronic exposure, route of administration, and behavioral responses. CONCLUSIONS: The selected examples of successful dosaging ranges are provided, while emphasizing the necessity of empirically determined dose-response relationships based on the precise parameters and conditions inherent to a specific hypothesis. This review provides a new, experimentally based compilation of species-specific dose selection for studies on the in vivo effects of nicotine.


Subject(s)
Behavioral Research/methods , Dose-Response Relationship, Drug , Guidelines as Topic , Nicotine/administration & dosage , Animals , Ganglionic Stimulants/administration & dosage , Ganglionic Stimulants/metabolism , Ganglionic Stimulants/pharmacokinetics , Humans , Models, Biological , Nicotine/metabolism , Nicotine/pharmacokinetics , Species Specificity
3.
EMBO Rep ; 5(11): 1058-63, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15514678

ABSTRACT

The p38 mitogen-activated protein kinase (MAPK) cascade is an evolutionarily conserved signalling mechanism involved in processes as diverse as apoptosis, cell fate determination, immune function and stress response. Aberrant p38 signalling has been implicated in many human diseases, including heart disease, cancer, arthritis and neurodegenerative diseases. To further understand the role of p38 in these processes, we generated a Drosophila strain that is null for the D-p38a gene. Mutants are homozygous viable and show no observable developmental defects. However, flies lacking D-p38a are susceptible to some environmental stresses, including heat shock, oxidative stress and starvation. These phenotypes only partially overlap those caused by mutations in D-MEKK1 and dTAK1, suggesting that the D-p38a gene is required to mediate some, but not all, of the functions ascribed to p38 signalling.


Subject(s)
p38 Mitogen-Activated Protein Kinases/physiology , Animals , Blotting, Northern , Drosophila melanogaster , Environment , Genotype , Homozygote , Hot Temperature , Hydrogen Peroxide/pharmacology , Models, Genetic , Mutagenesis , Mutation , Oligonucleotide Array Sequence Analysis , Phenotype , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , Temperature , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...